Author: Delia Tatulescu (Romania)
Co-authors: Sorin Macarie
Purpose
Description of a unilateral case of non-arteritic ischaemic optic neuropathy (NAION) with atypical features in a patient with long-term amiodarone treatment. Amiodarone-associated optic neuropathy (AAON) is a controversial entity at the present, as it shares many similarities with NAION, the most common optic nerve disorder that leads to sudden onset of vision loss in elderly patients. It usually occurs within the first year of treatment. The classic characteristics include: insidious onset, bilateral involvement and slow resolution of the papillary swelling. In addition to these elements, there is a more complex clinical assessment of the following features: mild degree of optic nerve dysfunction (preserved or mild decrease in visual acuity and low probability of relative afferent pupillary defect [RAPD]), structure of uninvolved disc in unilateral cases, and systemic toxic effects, when present.
Setting/Venue
Clinic of Ophthalmology, Cluj Napoca County Emergency Hospital, Romania
Methods
Retrospective description of clinical case based on international scientific data evidence. Data collected structured according to: age; laterality of disc swelling; onset of decrease in visual acuity (VA); amiodarone dosage per day, respectively cumulative dosage per week; VA involved eye, at the moment of the visit, and when possible, at the 3-month follow-up; visual field (VF) of involved eye; presence of RAPD; Cup/disc ratio (CDR) of uninvolved eye; presence of potential toxic systemic effects and time to resolution of papillary edema, if documented.
Results
Female patient, 69 years old, at her first ophthalmological visit, presents with insidious unilateral onset of decrease in VA of the left eye (LE). Patient remains hospitalized. Documentation of amiodarone intake of 200 mg/day (1400 g/week) for the past several years with antihypertensive and anticoagulant co-medication. Best corrected visual acuity (BCVA) for right eye (RE) 5/10 and in the involved eye (LE) 4/10, no RAPD. Anterior segment findings: Vortex Keratopathy and nuclear sclerotic cataract in both eyes (OU), the nuclear opacities being denser in RE. Fundoscopy reveals in RE slight disc pallor, whereas in LE mild papillary swelling, hyperemic disc with one hemorrhage inferiorly. CDR in uninvolved eye is 0,1. VF RE shows generalized decrease in retinal sensitivity; VF LE with generalized decrease in retinal sensitivity with superior altitudinal defect. Inflammatory and cardiovascular work-up is normal. Magnetic resonance imaging (MRI) identifies cerebral microangiopathy. Systemic intravenous steroids are administered during hospitalization with slow tapering of dosage. At discharge, BCVA slightly improved in LE (6/10), with no resolution of papillary swelling. Unfortunately, patient is lost at follow-up.
Conlusions
Patients undergoing amiodarone treatment should be considered for regular ophthalmological follow-up, in close collaboration with cardiologists, especially in the case of the high cardiovascular risk patients. Separation of the two entities NAION and AAON is difficult. There is a need for a guided monitoring protocol, that should primarily include VA, VF, fundoscopy and follow-up for reevaluation of resolution in the papillary edema and potential sequential disc swelling of the fellow eye when confronted with unilateral cases. Because of its various clinical presentation, one could hardly tell if it is a drug related condition with need for regular interdisciplinary collaboration, or whether it is a variant of NAION in patients at high risk for cardiovascular disease.
Financial Disclosure
NONE
Comments
-